lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia
出版年份 2022 全文链接
标题
lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia
作者
关键词
-
出版物
Stem Cells International
Volume 2022, Issue -, Pages 1-20
出版商
Hindawi Limited
发表日期
2022-09-09
DOI
10.1155/2022/9993393
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exosomal Long Non-coding RNA HOTTIP Increases Resistance of Colorectal Cancer Cells to Mitomycin via Impairing MiR-214-Mediated Degradation of KPNA3
- (2021) Xijuan Chen et al. Frontiers in Cell and Developmental Biology
- Third-line therapy for chronic myeloid leukemia: current status and future directions
- (2021) Jorge Cortes et al. Journal of Hematology & Oncology
- Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance
- (2021) Raquel Alves et al. Cancers
- Response and Resistance to BCR-ABL1-Targeted Therapies
- (2020) Theodore P. Braun et al. CANCER CELL
- HOTTIP Predicts Poor Survival in Gastric Cancer Patients and Contributes to Cisplatin Resistance by Sponging miR-216a-5p
- (2020) Rui Zhao et al. Frontiers in Cell and Developmental Biology
- The HOTTIP (HOXA transcript at the distal tip) lncRNA: Review of oncogenic roles in human
- (2020) Soudeh Ghafouri-Fard et al. BIOMEDICINE & PHARMACOTHERAPY
- EZH2 in Myeloid Malignancies
- (2020) Jenny Rinke et al. Cells
- Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- (2020) Michael W. Deininger et al. Journal of the National Comprehensive Cancer Network
- Chronic myeloid leukemia stem cells
- (2019) Mohammad Houshmand et al. LEUKEMIA
- BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
- (2019) Federica Loscocco et al. Frontiers in Oncology
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
- (2017) Xun Jin et al. NATURE MEDICINE
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- BCR/ABL increases EZH2 levels which regulates XIAP expression via miRNA-219 in chronic myeloid leukemia cells
- (2016) Chie Nishioka et al. LEUKEMIA RESEARCH
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Unique features of long non-coding RNA biogenesis and function
- (2016) Jeffrey J. Quinn et al. NATURE REVIEWS GENETICS
- Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
- (2016) M. T. Scott et al. Cancer Discovery
- Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2
- (2016) H. Xie et al. Cancer Discovery
- DNMT3A in Leukemia
- (2016) Lorenzo Brunetti et al. Cold Spring Harbor Perspectives in Medicine
- EZH2 expands breast stem cells through activation of NOTCH1 signaling
- (2014) M. E. Gonzalez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
- (2012) Lilian E. van Vlerken et al. Stem Cells Translational Medicine
- Translation of the Philadelphia chromosome into therapy for CML
- (2008) B. J. Druker BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now